/5
0 avis
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial
Archive ouverte
Edité par CCSD ; American Medical Association -
Consulter en ligne
Chargement des enrichissements...